TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8479193

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) alone (n = 15)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) in combination with external beam (n = 27)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT)
Number of subjects: 87
Study: 3296153

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 29751787

Group type: EXPERIMENTAL
Intervention: Interferon beta-1a SC 44 μg 3×/week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon beta-1a SC 22 μg 3×/week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/delayed treatment (DTx)
Number of subjects: 0
Study: 26893248

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine iontophoresis using interferential current
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interferential current
Number of subjects: 30
Study: 22735030

Group type: EXPERIMENTAL
Intervention: Dietary counselling focusing on dietary fat, fibre and saccharose intake at four routine maternity clinic visits
Number of subjects: 399
Study: 22736022

Group type: EXPERIMENTAL
Intervention: Single-segment fixation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Short-segment fixation
Number of subjects: 106
Study: 20448462

Group type: EXPERIMENTAL
Intervention: Nimotuzumab plus radiotherapy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo plus radiotherapy
Number of subjects: 106
Study: 18702958

Group type: EXPERIMENTAL
Intervention: Miglitol (50 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20552096

Group type: EXPERIMENTAL
Intervention: Spring-loaded bite blocks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Magnetic bite blocks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Both appliances
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 16607791

Group type: EXPERIMENTAL
Intervention: Piroxicam 0.5%
Number of subjects: 75

Group type: COMPARATOR
Intervention: Diclofenac 0.1%
Number of subjects: 75

Group type: COMPARATOR
Intervention: Indomethacin 0.1%
Number of subjects: 75
Study: 12069449

Group type: EXPERIMENTAL
Intervention: Creatinine clearance ≤ 40 ml x min(‐1)
Number of subjects: 6252

Group type: EXPERIMENTAL
Intervention: Creatinine clearance from 41 to 55 ml x min(‐1)
Number of subjects: 6252

Group type: EXPERIMENTAL
Intervention: Creatinine clearance from 71 to 85 ml x min(‐1)
Number of subjects: 6252
Study: 9713031

Group type: EXPERIMENTAL
Intervention: Patient Triggered Ventilation (PTV)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional Mandatory Ventilation (CMV)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (babies who died)
Number of subjects: 59
Study: 7980596

Group type: EXPERIMENTAL
Intervention: Cys311 variant allele in alcoholics
Number of subjects: 569

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 569
Study: 2925978

Group type: EXPERIMENTAL
Intervention: Active nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 0
Study: 29105516

Group type: EXPERIMENTAL
Intervention: Active cycling program (n=33; 3 months, 3x30 minutes training/week)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Active cycling group (n=33)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Coaching group (n=15)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Non-coaching group (n=16)
Number of subjects: 59
Study: 29873212

Group type: EXPERIMENTAL
Intervention: Psychological intervention combined with diazepam (2.5 mg once, twice a day)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Routine treatment of sudden hearing loss (Control group)
Number of subjects: 108
Study: 27063750

Group type: EXPERIMENTAL
Intervention: Experimental internal nasal dilator (IND)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo internal nasal dilator (IND)
Number of subjects: 54
Study: 23113597

Group type: EXPERIMENTAL
Intervention: Resonance frequency analysis (RFA) measurements at 8 weeks post-implant placement
Number of subjects: 28

Group type: COMPARATOR
Intervention: Resonance frequency analysis (RFA) measurements at implant placement
Number of subjects: 28
Study: 22240263

Group type: EXPERIMENTAL
Intervention: Colestimide 3 g/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pravastatin alone
Number of subjects: 40
Study: 21173510

Group type: EXPERIMENTAL
Intervention: Same-day discharge transradial percutaneous coronary intervention (TRI)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Outpatient department PCI with subsequent admission
Number of subjects: 660

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 660
Study: 17554695

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (IPTi) after first dose
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (IPTi) after second dose
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (IPTi) after third dose
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (IPTi) for first anemia episode
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (IPTi) after last dose
Number of subjects: 1070
Study: 15803071

Group type: EXPERIMENTAL
Intervention: Manual therapy and spinal stabilization exercises (30 minutes, 8 treatments over 8 weeks)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10 station exercise class (aerobic exercises, spinal stabilization exercises, and manual therapy, 8 treatments over 8 weeks)
Number of subjects: 80
Study: 12480510

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment with standard needles at acupoint LI11 for 30 min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo treatment with placebo needles at acupoint LI11 for 30 min
Number of subjects: 14
Study: 10088835

Group type: EXPERIMENTAL
Intervention: Water seal group
Number of subjects: 205

Group type: COMPARATOR
Intervention: No water seal group
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 205
Study: 7738860

Group type: EXPERIMENTAL
Intervention: Imagination of treadmill exercise in athletes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control task (imaging letters)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control task (treadmill sound only)
Number of subjects: 12
Study: 2289222

Group type: EXPERIMENTAL
Intervention: beta‐cyclodextrin‐piroxicam (20 mg daily for eight weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: tenoxicam (dosage not specified, for eight weeks)
Number of subjects: 30
Study: 7002483

Group type: EXPERIMENTAL
Intervention: Rociverine (10 or 20 mg given intravenously)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Hyoscine butylbromide (20 or 40 mg given intravenously)
Number of subjects: 121
Study: 31437287

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 67

Group type: COMPARATOR
Intervention: Routine hospital fall prevention protocols
Number of subjects: 67
Study: 29217923

Group type: EXPERIMENTAL
Intervention: Peer-led approach and health clubs linked with school events and parents
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Peer-led approach and health clubs
Number of subjects: 1000
Study: 26476796

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study: 23429925

Group type: EXPERIMENTAL
Intervention: Tailor-made weight loss intervention
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control group (oral glucosamine sulphate)
Number of subjects: 407
Study: 23185985

Group type: EXPERIMENTAL
Intervention: Web-based personalized feedback intervention offered to participants
Number of subjects: 425

Group type: COMPARATOR
Intervention: Control condition (intervention not offered)
Number of subjects: 425
Study: 18613283

Group type: EXPERIMENTAL
Intervention: Integrated care condition (harm-reduction based approach)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Enhanced referral condition
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Integrated care condition
Number of subjects: 34
Study: 17522506

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b 10 MIU/m (IFN-I group) thrice weekly for 16 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b 30 MIU/m (IFN-II group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon therapy
Number of subjects: 80
Study: 15221054

Group type: COMPARATOR
Intervention: UDC + CDC (125 mg urso-/chenodeoxycholic acid per 25 kg body weight)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: M + UDC + CDC (62.5 mg UDC/CDC plus 125 mg menthol per 25 kg body weight)
Number of subjects: 70
Study: 12063630

Group type: EXPERIMENTAL
Intervention: Fusafungine in spray 4 times daily
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (standard postoperative therapy)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Fusafungine in spray
Number of subjects: 68
Study: 9640721

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control
Number of subjects: 122
Study: 7855226

Group type: EXPERIMENTAL
Intervention: Pindolol, 30 mg orally
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-5-HTP, 200 mg PO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pindolol alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: L-5-HTP
Number of subjects: 12
Study: 2517747

Group type: EXPERIMENTAL
Intervention: Listening to a tale
Number of subjects: 100

Group type: COMPARATOR
Intervention: Formal explanations at the classroom
Number of subjects: 100
Study: 998549

Group type: EXPERIMENTAL
Intervention: 2.5 mg of pyridoxine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg of pyridoxine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 mg of pyridoxine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary intake of vitamin B6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recommended Dietary Allowance for vitamin B6 during pregnancy
Number of subjects: 0
Study: 30700262

Group type: EXPERIMENTAL
Intervention: Multilevel intervention including SMS text messages, social support in walking groups, and community events
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control communities (n=600)
Number of subjects: 600
Study: 28064469

Group type: EXPERIMENTAL
Intervention: Multimodal, psychodynamically oriented psychotherapy for 8 weeks
Number of subjects: 40
Study: 25720410

Group type: EXPERIMENTAL
Intervention: Impaired cerebrovascular reactivity (CVR) defined by breath-holding index (BHI <0.47; bottom quartile)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Impaired CVR in patients with carotid large-vessel disease
Number of subjects: 415
Study: 23676940

Group type: EXPERIMENTAL
Intervention: SCIT combined with standardized treatment for asthma
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standardized treatment alone
Number of subjects: 90
Study: 21851904

Group type: EXPERIMENTAL
Intervention: BES (biolimus-eluting stents)
Number of subjects: 1707

Group type: COMPARATOR
Intervention: SES (sirolimus-eluting stents)
Number of subjects: 1707

Group type: EXPERIMENTAL
Intervention: BES
Number of subjects: 1707

Group type: COMPARATOR
Intervention: SES
Number of subjects: 1707
Study: 18372063

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (1-7 drinks/week)
Number of subjects: 5477

Group type: COMPARATOR
Intervention: Non-drinkers (abstainers)
Number of subjects: 5477
Study: 17505249

Group type: EXPERIMENTAL
Intervention: Sterile single-use catheters
Number of subjects: 13

Group type: COMPARATOR
Intervention: Clean reused catheters
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Coated catheters
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Uncoated PVC catheters
Number of subjects: 13
Study: 14747232

Group type: EXPERIMENTAL
Intervention: Internet-based blood glucose monitoring system (IBGMS) for 12 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group with usual outpatient management for 12 weeks
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Internet-based blood glucose monitoring system (IBGMS) for patients with baseline HbA(1c) <7.0%
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Internet-based blood glucose monitoring system (IBGMS) for patients with baseline HbA(1c) >= 7.0%
Number of subjects: 110
Study: 11527798

Group type: EXPERIMENTAL
Intervention: Bulaquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primaquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 9578250

Group type: EXPERIMENTAL
Intervention: Patient-controlled propofol administration
Number of subjects: 19

Group type: COMPARATOR
Intervention: Operator-controlled propofol administration
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both methods (patient-controlled and operator-controlled)
Number of subjects: 19
Study: 7715982

Group type: EXPERIMENTAL
Intervention: Cold-adapted influenza A reassortant virus vaccine (10^5 or 10^6 TCID50) administered separately from routine immunizations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold-adapted influenza A reassortant virus vaccine (10^6 TCID50) administered with routine immunizations at 2 and 4 months of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold-adapted influenza A reassortant virus vaccine (10^6 TCID50) administered with routine immunizations at 2 and 6 months of age
Number of subjects: 0
Study: 2515717

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 10
Study: 31464520

Group type: EXPERIMENTAL
Intervention: Identified 14 driver genes associated with HCC
Number of subjects: 1074

Group type: EXPERIMENTAL
Intervention: Pathway crosstalk and protein interaction network analysis
Number of subjects: 1074

Group type: EXPERIMENTAL
Intervention: Functional analysis of 560 human genes
Number of subjects: 1074
Study: 28454828

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (36 supervised sessions followed by home-based training)
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2331
Study: 25591054

Group type: EXPERIMENTAL
Intervention: Verticalization with a tilt table at 65° and movement of the lower limbs with a robotic system for 30 minutes three times a week for 24 sessions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Robotic verticalization system with inactive lower‐limb movement system
Number of subjects: 12
Study: 23443221

Group type: EXPERIMENTAL
Intervention: Rhodiola rosea (3 mg·kg(‐1))
Number of subjects: 18
Study: 21091330

Group type: EXPERIMENTAL
Intervention: AC-CPR mode
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard defibrillator operation
Number of subjects: 30
Study: 19566636

Group type: EXPERIMENTAL
Intervention: Regular family visiting program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 16761891

Group type: EXPERIMENTAL
Intervention: Comprehensive behavioral intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study: 15531698

Group type: EXPERIMENTAL
Intervention: 30 mg elemental Fe as (57)Fe-labeled sprinkles added to maize-based porridge
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 45 mg elemental Fe as (57)Fe-labeled sprinkles added to maize-based porridge
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: (58)Fe tracer (0.2 mg as ferrous citrate) infused intravenously
Number of subjects: 90
Study: 15353051

Group type: EXPERIMENTAL
Intervention: Written prompt to elicit patient's concerns
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual consultation
Number of subjects: 110
Study: 11061523

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) infusion at 1, 2, or 4 mIU/min for 10 hours
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone (dex; 4 mg, iv) followed by OT infusion at 1 mIU/min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone (dex; 4 mg, iv) followed by OT infusion at 2 or 4 mIU/min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone (dex; 4 mg, iv) in obese subjects
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) infusion at 1, 2, or 4 mIU/min in obese subjects
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone (dex; 4 mg, iv) with OT infusion in obese subjects
Number of subjects: 19
Study: 9117220

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simulated treatment (placebo-like)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 120
Study: 8450101

Group type: EXPERIMENTAL
Intervention: High-information preparation condition
Number of subjects: 72

Group type: COMPARATOR
Intervention: Low-information preparation condition
Number of subjects: 72
Study: 2439799

Group type: EXPERIMENTAL
Intervention: Bisoprolol (BPL) 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol (ATL) 100 mg
Number of subjects: 8
Study: 2701823

Group type: EXPERIMENTAL
Intervention: EMG biofeedback treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control treatment (routine physiotherapy)
Number of subjects: 40
Study: 31562572

Group type: EXPERIMENTAL
Intervention: Sheroes (n=39)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (n=38)
Number of subjects: 77
Study: 31164168

Group type: EXPERIMENTAL
Intervention: Daily electronic patient-reported outcome (PRO) diaries
Number of subjects: 0
Study: 27778463

Group type: EXPERIMENTAL
Intervention: Visual field assessment
Number of subjects: 249

Group type: COMPARATOR
Intervention: Optic disc photography
Number of subjects: 249
Study: 26398071

Group type: EXPERIMENTAL
Intervention: Gonadotropin
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 900

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 900
Study: 23744329

Group type: EXPERIMENTAL
Intervention: SNP rs45514798 in MK2 gene
Number of subjects: 930

Group type: COMPARATOR
Intervention: ZFP36 gene polymorphisms
Number of subjects: 930
Study: 21423758

Group type: EXPERIMENTAL
Intervention: G-CSF (10 µg/kg BW)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 18248549

Group type: EXPERIMENTAL
Intervention: Peer coaches conducting AIDS education within sport (with mastery coaching strategies)
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Peer coaches conducting AIDS education within sport (without mastery coaching strategies)
Number of subjects: 764

Group type: COMPARATOR
Intervention: Traditional in-school AIDS education
Number of subjects: 764

Group type: COMPARATOR
Intervention: No education (out-of-school children)
Number of subjects: 764
Study: 17490568

Group type: EXPERIMENTAL
Intervention: Fluid resuscitation (250 ml bolus every 15 minutes until ITBVI>850 ml/m(2))
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fluid resuscitation
Number of subjects: 20
Study: 15505442

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 6

Group type: COMPARATOR
Intervention: Recovery from Remifentanil
Number of subjects: 6
Study: 11448424

Group type: EXPERIMENTAL
Intervention: Intra-arterial recombinant fibroblast growth factor-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9720857

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Relaxation)
Number of subjects: 60
Study: 7986708

Group type: EXPERIMENTAL
Intervention: EPO 150 U/kg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: EPO 300 U/kg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: EPO 600 U/kg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 2688147

Group type: EXPERIMENTAL
Intervention: 200‐mg of enoxacin twice a day for two days
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 400‐mg of enoxacin twice a day for two days
Number of subjects: 51
Study: 1137386

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gentamicin C(1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gentamicin and Gentamicin C(1)
Number of subjects: 0
Study: 31496653

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal Controls (NCs)
Number of subjects: 70
Study: 29282152

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (50% maximum inspiratory pressure, twice daily for 4 weeks)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham inspiratory muscle training
Number of subjects: 65
Study: 26248140

Group type: EXPERIMENTAL
Intervention: Online cognitive training platform
Number of subjects: 80

Group type: COMPARATOR
Intervention: Communication or assistive features
Number of subjects: 80
Study: 23769263

Group type: EXPERIMENTAL
Intervention: Ischemic compression (IC) group (n=24)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Passive stretching group (n=23)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Muscle energy technique group (n=23)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Wait-and-see group (n=25)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo group (n=22)
Number of subjects: 117
Study: 21521911

Group type: EXPERIMENTAL
Intervention: Ceram X (Nano Ceramic restorative material)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Admira (Ormocer‐based composite)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Beautifil (Giomer)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fuji IX (Glass ionomer cement)
Number of subjects: 60